288 related articles for article (PubMed ID: 29940911)
21. IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth.
Venmar KT; Kimmel DW; Cliffel DE; Fingleton B
Biochim Biophys Acta; 2015 May; 1853(5):1219-28. PubMed ID: 25746764
[TBL] [Abstract][Full Text] [Related]
22. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells.
Kobayashi K; Ohnishi A; Promsuk J; Shimizu S; Kanai Y; Shiokawa Y; Nagane M
Neurosurgery; 2008 Feb; 62(2):493-503; discussion 503-4. PubMed ID: 18382329
[TBL] [Abstract][Full Text] [Related]
23. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
[TBL] [Abstract][Full Text] [Related]
24. Glutamine metabolism in breast cancer and possible therapeutic targets.
Li S; Zeng H; Fan J; Wang F; Xu C; Li Y; Tu J; Nephew KP; Long X
Biochem Pharmacol; 2023 Apr; 210():115464. PubMed ID: 36849062
[TBL] [Abstract][Full Text] [Related]
25. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors.
Fan X; Ross DD; Arakawa H; Ganapathy V; Tamai I; Nakanishi T
Biochem Pharmacol; 2010 Sep; 80(6):811-8. PubMed ID: 20510678
[TBL] [Abstract][Full Text] [Related]
26. The Adipose Tissue-Derived Secretome (ADS) in Obesity Uniquely Induces L-Type Amino Acid Transporter 1 (LAT1) and mTOR Signaling in Estrogen-Receptor-Positive Breast Cancer Cells.
Thompson C; Rahman MM; Singh S; Arthur S; Sierra-Bakhshi C; Russell R; Denning K; Sundaram U; Salisbury T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201429
[TBL] [Abstract][Full Text] [Related]
27. Taxol induced apoptosis regulates amino acid transport in breast cancer cells.
Wu Y; Shen D; Chen Z; Clayton S; Vadgama JV
Apoptosis; 2007 Mar; 12(3):593-612. PubMed ID: 17195090
[TBL] [Abstract][Full Text] [Related]
28. Bone metastatic breast cancer cells display downregulation of PKC-ζ with enhanced glutamine metabolism.
Tandon M; Othman AH; Winogradzki M; Pratap J
Gene; 2021 Apr; 775():145419. PubMed ID: 33444686
[TBL] [Abstract][Full Text] [Related]
29. L-type amino acid transporter 1 is associated with chemoresistance in breast cancer via the promotion of amino acid metabolism.
Sato M; Harada-Shoji N; Toyohara T; Soga T; Itoh M; Miyashita M; Tada H; Amari M; Anzai N; Furumoto S; Abe T; Suzuki T; Ishida T; Sasano H
Sci Rep; 2021 Jan; 11(1):589. PubMed ID: 33436954
[No Abstract] [Full Text] [Related]
30. GPNA inhibits the sodium-independent transport system L for neutral amino acids.
Chiu M; Sabino C; Taurino G; Bianchi MG; Andreoli R; Giuliani N; Bussolati O
Amino Acids; 2017 Aug; 49(8):1365-1372. PubMed ID: 28516268
[TBL] [Abstract][Full Text] [Related]
31. Significance of gamma-glutamyl transpeptidase and thiols in amino acid uptake by rat pancreatic islets: studies with glutamine and leucine.
Ammon HP; Fuss A; Verspohl EJ
Cell Biochem Funct; 1988 Oct; 6(4):271-4. PubMed ID: 2903803
[TBL] [Abstract][Full Text] [Related]
32. Diverse Roads Taken by
Gkiouli M; Biechl P; Eisenreich W; Otto AM
Cells; 2019 Sep; 8(10):. PubMed ID: 31547005
[TBL] [Abstract][Full Text] [Related]
33. Properties of L-type amino acid transporter 1 in epidermal ovarian cancer.
Kaji M; Kabir-Salmani M; Anzai N; Jin CJ; Akimoto Y; Horita A; Sakamoto A; Kanai Y; Sakurai H; Iwashita M
Int J Gynecol Cancer; 2010 Apr; 20(3):329-36. PubMed ID: 20375792
[TBL] [Abstract][Full Text] [Related]
34. Roles of acid-extruding ion transporters in regulation of breast cancer cell growth in a 3-dimensional microenvironment.
Andersen AP; Flinck M; Oernbo EK; Pedersen NB; Viuff BM; Pedersen SF
Mol Cancer; 2016 Jun; 15(1):45. PubMed ID: 27266704
[TBL] [Abstract][Full Text] [Related]
35. Mass spectrometry analysis shows the biosynthetic pathways supported by pyruvate carboxylase in highly invasive breast cancer cells.
Phannasil P; Ansari IH; El Azzouny M; Longacre MJ; Rattanapornsompong K; Burant CF; MacDonald MJ; Jitrapakdee S
Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):537-551. PubMed ID: 27890529
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Glutamine Cellular Uptake Contributes to the Cytotoxic Effect of Xanthohumol in Triple-Negative Breast Cancer Cells.
Carmo F; Silva C; Martel F
Nutr Cancer; 2022; 74(9):3413-3430. PubMed ID: 35594207
[TBL] [Abstract][Full Text] [Related]
37. Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.
Todorova VK; Kaufmann Y; Luo S; Klimberg VS
Cancer Chemother Pharmacol; 2011 Feb; 67(2):285-91. PubMed ID: 20383709
[TBL] [Abstract][Full Text] [Related]
38. The Regulation and Function of the L-Type Amino Acid Transporter 1 (LAT1) in Cancer.
Salisbury TB; Arthur S
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103560
[TBL] [Abstract][Full Text] [Related]
39. The astroglial ASCT2 amino acid transporter as a mediator of glutamine efflux.
Bröer A; Brookes N; Ganapathy V; Dimmer KS; Wagner CA; Lang F; Bröer S
J Neurochem; 1999 Nov; 73(5):2184-94. PubMed ID: 10537079
[TBL] [Abstract][Full Text] [Related]
40. LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
Marshall AD; van Geldermalsen M; Otte NJ; Anderson LA; Lum T; Vellozzi MA; Zhang BK; Thoeng A; Wang Q; Rasko JE; Holst J
Int J Cancer; 2016 Dec; 139(11):2529-39. PubMed ID: 27486861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
